Authors

  1. Aschenbrenner, Diane S. MS, RN

Abstract

* A new selective serotonin reuptake inhibitor, vilazodone hydrochloride (Viibryd), has been approved for the treatment of depression.

 

* Vilazodone's mechanism of action is similar to that of other drugs in the class, and it carries similar warnings and precautions.

 

* Vilazodone should be taken with food, which increases its bioavailability.